VEGFA c.1021_1022delinsGC ;(p.K341A)

Variant ID: 6-43748527-AA-GC

NM_003376.5(VEGFA):c.1021_1022delinsGC;(p.K341A)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


Current Targets and Bioconjugation Strategies in Photodynamic Diagnosis and Therapy of Cancer.

Molecules (Basel, Switzerland)
Gomez, Salvador S; Tsung, Allan A; Hu, Zhiwei Z
Publication Date: 2020-10-27

Variant appearance in text: VEGF: K341A
PubMed Link: 33121022
Variant Present in the following documents:
  • Main text
  • molecules-25-04964.pdf
View BVdb publication page



Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases.

Antibodies (Basel, Switzerland)
Hu, Zhiwei Z
Publication Date: 2018-03

Variant appearance in text: VEGF: K341A
PubMed Link: 31105982
Variant Present in the following documents:
  • Main text
  • antibodies-07-00008.pdf
View BVdb publication page



Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer.

Oncotarget
Hu, Zhiwei Z; Xu, Jie J; Cheng, Jijun J; McMichael, Elizabeth E; Yu, Lianbo L; Carson, William E WE
Publication Date: 2017-01-03

Variant appearance in text: VEGF: K341A
PubMed Link: 27903969
Variant Present in the following documents:
  • Main text
  • oncotarget-08-1481.pdf
View BVdb publication page



Tissue factor is an angiogenic-specific receptor for factor VII-targeted immunotherapy and photodynamic therapy.

Angiogenesis
Hu, Zhiwei Z; Cheng, Jijun J; Xu, Jie J; Ruf, Wolfram W; Lockwood, Charles J CJ
Publication Date: 2017-02

Variant appearance in text: VEGF: K341A
PubMed Link: 27807692
Variant Present in the following documents:
  • Main text
  • 10456_2016_Article_9530.pdf
View BVdb publication page



Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancer.

Bmc Immunology
Hu, Zhiwei Z; Li, Jing J
Publication Date: 2010-10-12

Variant appearance in text: VEGF: K341A
PubMed Link: 20939894
Variant Present in the following documents:
  • Main text
  • 1471-2172-11-49.pdf
View BVdb publication page



Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer.

Breast Cancer Research And Treatment
Hu, Zhiwei Z; Rao, Benqiang B; Chen, Shimin S; Duanmu, Jinzhong J
Publication Date: 2011-04

Variant appearance in text: VEGF: K341A
PubMed Link: 20514515
Variant Present in the following documents:
  • Main text
View BVdb publication page



Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.

Bmc Cancer
Hu, Zhiwei Z; Rao, Benqiang B; Chen, Shimin S; Duanmu, Jinzhong J
Publication Date: 2010-05-26

Variant appearance in text: VEGF: lys341Ala
PubMed Link: 20504328
Variant Present in the following documents:
  • Main text
  • 1471-2407-10-235.pdf
View BVdb publication page